Jun Qi
Fujian University of Traditional Chinese Medicine(CN)Nanjing Agricultural University(CN)Harvard University(US)Anhui Agricultural University(CN)Shenyang University of Technology(CN)Linyi University(CN)First People's Hospital of Yunnan Province(CN)Daqing Oilfield General Hospital(CN)Dana-Farber Cancer Institute(US)Gansu Provincial Maternal and Child Health Hospital(CN)Taiho Pharmaceutical (Japan)(JP)Cancer Research Center(US)Ministry of Agriculture and Rural Affairs(CN)Nanchang Center for Disease Control and Prevention(CN)Baotou Medical College(CN)Xi’an Jiaotong-Liverpool University(CN)Shandong Institute of Business and Technology(CN)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Chromatin Remodeling and Cancer, Multiple Myeloma Research and Treatments, Histone Deacetylase Inhibitors Research, Peptidase Inhibition and Analysis
Most-Cited Works
- → Selective inhibition of BET bromodomains(2010)4,234 cited
- → BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc(2011)2,818 cited
- → RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia(2011)1,858 cited
- → R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling(2017)1,171 cited
- → The dTAG system for immediate and target-specific protein degradation(2018)1,126 cited
- → Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma(2013)757 cited